It is a pharma private limited company based in Noida, Uttar Pradesh, India, established in 2021.
2021 | Noida, Uttar Pradesh, India | ActiveXcelent Pharmaceuticals Private Limited, a active private limited company, was established on 30 January 2021 in Noida, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230UP2021PTC140979. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.10 M.
Its leadership includes Shikha Sharma (Director), Premlata Rastogi (Director), Ram Lal Rastogi (Director). Past directors included Avinash Kumar Singh. It holds ₹4.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Cs- 6/1203 Supertech Capetown Sector 74, Noida, Uttar Pradesh, 201301.
U24230UP2021PTC140979
140979
30 January 2021
₹0.40 M
₹0.10 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Xcelent Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shikha Sharma | Director | 12 Aug 2023 | Current |
| Premlata Rastogi | Director | 30 Jan 2021 | Current |
| Ram Lal Rastogi | Director | 30 Jan 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 26 Oct 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Xcelent Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 68.72% increase. The company also saw a substantial improvement in profitability, with a 233.51% increase in profit. The company's net worth Soared by an impressive increase of 65.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Xcelent Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹4,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Mar 2024 | State Bank Of India | ₹4.20 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Xcelent Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Xcelent Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Xcelent Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Xcelent Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
The activity A charge with State Bank Of India of Rs. 4.20 M registered on 13 Mar 2024 with Charge ID 100892421 was modified on 28 Apr 2025. was completed.
Xcelent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur. was recorded as a recent event.
Progress on A charge with State Bank Of India amounted to Rs. 4.20 M with Charge ID 100892421 was registered on 13 Mar 2024. was documented.
The activity Shikha Sharma was appointed as a Director was appointed as a Director on 12 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
Progress on Premlata Rastogi was appointed as a Director was appointed as a Director on 30 Jan 2021 & has been associated with this company since 4 years 10 months . was documented.
The CIN of Xcelent Pharmaceuticals Private Limited is U24230UP2021PTC140979.
Xcelent Pharmaceuticals Private Limited is headquartered at Cs- 6/1203 Supertech Capetown Sector 74, Noida, Uttar Pradesh, 201301.
Xcelent Pharmaceuticals Private Limited was incorporated on 30 January 2021.
The current directors of Xcelent Pharmaceuticals Private Limited are
The primary industry of Xcelent Pharmaceuticals Private Limited is Trade.
Xcelent Pharmaceuticals Private Limited is unlisted.
The authorized capital of Xcelent Pharmaceuticals Private Limited is ₹0.40 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX